Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Chronic Heart Failure

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 113 articles: HTML format

Single Articles

January 2026
1. SZABO-SODERBERG B, Lund LH
   Response to letter by Naeem regarding article, "Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction".
   Am Heart J. 2026;291:214-215.
   PubMed    
   
   
   
2. NAEEM U, Qadir HA
   Letter to the editor: Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction.
   Am Heart J. 2026;291:213.
   PubMed    
   
   
   
3. ANNAPUREDDY AR, Murugiah K, Zheng L, Minges KE, et al
   Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry.
   Am Heart J. 2026;291:26-36.
   PubMed     Abstract available
   
   
   December 2025
4. LITWIN SE, Komtebedde J, Borlaug BA, Kaye DM, et al
   Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:1
   Am Heart J. 2025;293:107312.
   PubMed    
   
   
   November 2025
5. DEVASENAPATHY N, Biswas S, Kini P, Satheesh S, et al
   Digoxin in rheumatic heart disease: Rationale and design of a multicenter, placebo-controlled double-blind randomized controlled trial (Dig-RHD trial).
   Am Heart J. 2025;289:38-47.
   PubMed     Abstract available
   
   
   October 2025
6. STEVERSON AB, Fan J, Din N, Kalwani N, et al
   Differences in guideline directed medical therapy for rural and non-rural Veterans with heart failure with reduced ejection fraction.
   Am Heart J. 2025 Oct 31:107300. doi: 10.1016/j.ahj.2025.107300.
   PubMed     Abstract available
   
   
   
7. YE L, Girouard MP, Go AS, Liu JY, et al
   Worsening Heart Failure Events in Adults with Mild-to-Moderate Chronic Kidney Disease.
   Am Heart J. 2025 Oct 17:107290. doi: 10.1016/j.ahj.2025.107290.
   PubMed     Abstract available
   
   
   
8. OZONAT K, Centen C, Smith S, Aydemir B, et al
   Bioimpedance phase angle is associated with increased heart failure hospitalization risk.
   Am Heart J. 2025 Oct 6:107288. doi: 10.1016/j.ahj.2025.107288.
   PubMed     Abstract available
   
   
   
9. RAMBARAT P, Erickson T, Cyr D, Ward J, et al
   Effects of angiotensin-neprilysin inhibition in women vs men: Insights from PARAGLIDE-HF.
   Am Heart J. 2025;288:41-51.
   PubMed     Abstract available
   
   
   September 2025
10. MATSUMOTO S, Nasu T, Fujimoto W, Kagiyama N, et al
    Vericiguat and hypotension in patients with heart failure and reduced ejection fraction: VERIFY-HF registry.
    Am Heart J. 2025 Sep 22:S0002-8703(25)00335-7. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
11. ADATYA S, Naidu AS, Lee KK, Ambrosy AP, et al
    Enhancing Risk Stratification for Incident Systolic Heart Failure through Machine Learning and Natural Language Processing.
    Am Heart J. 2025 Sep 22:S0002-8703(25)00334-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
12. WONG J, Smith J, Soh CH, Howden E, et al
    Risk-Guided Disease Management To Prevent Heart Failure In Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial.
    Am Heart J. 2025 Sep 16:S0002-8703(25)00331-X. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
13. GOLDENBERG I, Zareba W, Ezekowitz JA, Albert C, et al
    Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial.
    Am Heart J. 2025 Sep 4:S0002-8703(25)00320-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    August 2025
14. HOLMEN S, Manintveld O, Damman K, Braun O, et al
    DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial.
    Am Heart J. 2025 Aug 19:S0002-8703(25)00300-X. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    July 2025
15. ILONZE OJ, Helmkamp LJ, McIlvennan CK, Allen LA, et al
    Trends in Urine Drug Screening and Positivity Among Patients with Heart Failure: Insights from a Large Health System.
    Am Heart J. 2025 Jul 10:S0002-8703(25)00216-9. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
16. KARSTEN M, Vignati C, Pezzuto B, Apostolo A, et al
    Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure.
    Am Heart J. 2025 Jul 9:S0002-8703(25)00209-1. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    June 2025
17. HANIF M, Khan LA, Kulkarni A, Bhatia HS, et al
    Global lipoprotein (a) testing trends from 2015 to 2023.
    Am Heart J. 2025 Jun 21:S0002-8703(25)00199-1. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
18. HOPPER I, Marwick TH, Wolfe R, Amerena J, et al
    STAREE-HEART: a randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants.
    Am Heart J. 2025 Jun 12:S0002-8703(25)00193-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
19. ZIMERMAN A, Dal Forno A, Rohde LE, Ternes CMP, et al
    Conduction System Pacing vs. Biventricular Resynchronization in Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block: Rationale and Design of the PhysioSync-HF Trial.
    Am Heart J. 2025 Jun 3:S0002-8703(25)00191-7. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
20. KHAN MS, Sauer AJ, Green CL, McDermott J, et al
    Rationale, Design, and Baseline Characteristics of the Virtual Care to Improve Heart Failure Outcomes (VITAL-HF) Trial.
    Am Heart J. 2025 Jun 3:S0002-8703(25)00190-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    May 2025
21. KITTIPIBUL V, Cyr DD, Harrington J, Lala A, et al
    Structural Abnormalities and Effects of Sacubitril/Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure: The PARAGLIDE-HF Trial.
    Am Heart J. 2025 May 22:S0002-8703(25)00161-9. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
22. SZABO-SODERBERG B, Benson L, Savarese G, Hage C, et al
    Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fraction.
    Am Heart J. 2025 May 6:S0002-8703(25)00155-3. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    April 2025
23. KITTIPIBUL V, Novelli A, Yaranov D, Swavely A, et al
    Relationship of Red Blood Cell Mass Profiles and Anemia Type to Outcomes and Cardiopulmonary Exercise Performance in Chronic Heart Failure.
    Am Heart J. 2025 Apr 28:S0002-8703(25)00143-7. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
24. PETERS AE, Li S, Cyr D, Williamson KM, et al
    Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: The PARAGLIDE-HF Trial.
    Am Heart J. 2025 Apr 21:S0002-8703(25)00139-5. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
25. DUPRE ME, Dhingra R, Xu H, Hammill BG, et al
    Racial and ethnic disparities in longitudinal trajectories of hospitalizations in patients diagnosed with heart failure.
    Am Heart J. 2025 Apr 8:S0002-8703(25)00123-1. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    March 2025
26. CHEN Y, Lawrence J, Stockbridge N
    Corrigendum to "Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials" [Am Heart J 241 (2021) 108-119].
    Am Heart J. 2025;285:105.
    PubMed    
    
    
    
27. ZEYMER U, Hassinger F, Bramlage P, Schafer A, et al
    Hyperoxemic Oxygen Therapy in Patients with Acute Anterior Myocardial Infarction: HOT-AAMI - Design and Rationale of a Randomized Trial.
    Am Heart J. 2025 Mar 21:S0002-8703(25)00095-X. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
28. YU J, Indraratna P, Briggs NE, Brown P, et al
    Rationale and design of the TeleClinical Care (TCC) -Cardiac trial: A pragmatic randomized trial of adjunctive virtual models of care in the secondary prevention of cardiovascular events.
    Am Heart J. 2025 Mar 11:S0002-8703(25)00091-2. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
29. DONAZZAN L, Bulian F, Maines M, Erckert M, et al
    Effect of rate-adaptive atrial support compared to VDD pacing in cardiac resynchronization therapy recipients: A randomized cross-over study.
    Am Heart J. 2025;281:149-156.
    PubMed     Abstract available
    
    
    
30. HARRINGTON J, Leyva M, Rao VN, Oakes M, et al
    Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators.
    Am Heart J. 2025;281:23-31.
    PubMed     Abstract available
    
    
    February 2025
31. TAKAHASHI T, Wei J, Iribarren AC, Gulati M, et al
    Rationale and design of the Women's Ischemia Syndrome Evaluation Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure With Preserved Ejection Fraction (WISE Pre-HFpEF).
    Am Heart J. 2025 Feb 24:S0002-8703(25)00056-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
32. PASQUALIN G, Misra A, Gauvreau K, Sanders SP, et al
    Ventricular-Arterial Coupling is associated with Clinical Outcomes in Patients with Systemic Right Ventricle.
    Am Heart J. 2025 Feb 19:S0002-8703(25)00043-2. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
33. SHOJI S, Cyr DD, Hernandez AF, Velazquez EJ, et al
    Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HF.
    Am Heart J. 2025;280:70-78.
    PubMed     Abstract available
    
    
    January 2025
34. KREINBROOK J, Rego E, Schlichte L, Barnes S, et al
    Towards a Person-Centered After-Visit Summary to Facilitate Improved Heart Failure Care (HF-AVS): A Scoping Review and Call to Action.
    Am Heart J. 2025 Jan 29:S0002-8703(25)00014-6. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
35. BALDI C, Maio MD, Esposito L, Bellino M, et al
    How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO Registry.
    Am Heart J. 2025 Jan 27:S0002-8703(25)00011-0. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
36. CHAIKIJURAJAI T, Chen HH, Tang WHW
    Baseline NT-proBNP Non-Response Score and Health Status Measures in Assessing Treatment Responses in Heart Failure with Reduced Ejection Fraction.
    Am Heart J. 2025 Jan 25:S0002-8703(25)00012-2. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available
    
    
    
37. SHECHTER A, Gupta A, Kaewkes D, Taheri H, et al
    Implications of an Off-Hours Setting in Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation.
    Am Heart J. 2025 Jan 2:S0002-8703(24)00341-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    December 2024
38. BULLOCK G, Jacobs JA, Carey JR, Pan IZ, et al
    Patterns of diuretic titration during inpatient management of acute decompensated heart failure.
    Am Heart J. 2024 Dec 27:S0002-8703(24)00339-9. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
39. ZHOU K, Alemayehu W, Rathwell S, McAlister FA, et al
    The Relationship of Diuretics and Dietary Sodium in Patients with Heart Failure: An Analysis of the SODIUM-HF Trial.
    Am Heart J. 2024 Dec 4:S0002-8703(24)00321-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
40. HWANG CS, Desai RJ, Kesselheim AS, Levin R, et al
    Primary Medication Adherence in Medicare Beneficiaries Prescribed Sacubitril-Valsartan or Renin-Angiotensin System Blockers for Heart Failure with Reduced Ejection Fraction.
    Am Heart J. 2024 Dec 3:S0002-8703(24)00316-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    October 2024
41. MAIDMAN SD, Blecker S, Reynolds HR, Phillips LM, et al
    Cardiologist Perceptions on Automated Alerts and Messages To Improve Heart Failure Care.
    Am Heart J. 2024 Oct 16:S0002-8703(24)00269-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
42. BALGOBIND A, Pierce M, Alviar C, Barnett C, et al
    Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North America.
    Am Heart J. 2024;276:115-119.
    PubMed     Abstract available
    
    
    September 2024
43. QAZI SU, Hamid A, Ansari HUH, Khouri MG, et al
    Trends in Cancer and Heart Failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020.
    Am Heart J. 2024 Sep 17:S0002-8703(24)00235-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
44. MEFFORD MT, Ambrosy AP, Wei R, Zheng C, et al
    Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction.
    Am Heart J. 2024 Sep 7:S0002-8703(24)00234-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
45. LITWIN SE, Komtebedde J, Borlaug BA, Kaye DM, et al
    Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials.
    Am Heart J. 2024 Sep 3:S0002-8703(24)00216-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
46. NELSON MD, Gomez-Arnold JM, Wei J, Lauzon M, et al
    Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) Study.
    Am Heart J. 2024 Sep 2:S0002-8703(24)00224-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
47. BOCKUS LB, Shadman R, Poole JE, Dardas TF, et al
    Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50.
    Am Heart J. 2024;275:35-44.
    PubMed     Abstract available
    
    
    August 2024
48. LUNDBERG S, Knigge P, Strange JE, Nouhravesh N, et al
    Temporal trends in infection-related hospitalizations among patients with heart failure: A Danish nationwide study from 1997-2017.
    Am Heart J. 2024 Aug 29:S0002-8703(24)00219-9. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
49. ANDERSEN CF, Omar M, Larsen JH, Kistorp C, et al
    Accelerometer-Measured Physical Activity in Patients with Heart Failure and Reduced Ejection Fraction: Determinants and Relationship with Patient-Reported Health Status.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00220-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
50. SANNA GD, Erre GL, Cameli M, Guerra F, et al
    Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00221-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
51. JIANG C, Wang Z, Du X, Wang Y, et al
    Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial.
    Am Heart J. 2024 Aug 23:S0002-8703(24)00203-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
52. FOX H
    Heart Failure and nocturnal hypoxemic burden, the connection is getting closer and closer.
    Am Heart J. 2024 Aug 21:S0002-8703(24)00207-2. doi: 10.1016/j.ahj.2024.
    PubMed    
    
    
    
53. LABARCA G
    Novel markers of nocturnal hypoxemia in sleep apnea and heart failure with reduced ejection fraction (HFrEF).
    Am Heart J. 2024 Aug 16:S0002-8703(24)00202-3. doi: 10.1016/j.ahj.2024.
    PubMed    
    
    
    
54. SOH CH, Wright L, Baumann A, Seidel B, et al
    Use of artificial intelligence-guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE-echo trial.
    Am Heart J. 2024;277:11-19.
    PubMed     Abstract available
    
    
    
55. DISMORR M, Granbom-Koski M, Ellfors E, Ruck A, et al
    Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.
    Am Heart J. 2024 Aug 9:S0002-8703(24)00185-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
56. MEDINA CK, Barnes SG, Felker GM, Mentz RJ, et al
    Severe obesity among patients with left ventricular assist devices.
    Am Heart J. 2024;274:130-133.
    PubMed     Abstract available
    
    
    
57. ARRIGO M, Davison B, Edwards C, Adamo M, et al
    Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
    Am Heart J. 2024;274:119-129.
    PubMed     Abstract available
    
    
    July 2024
58. ABDUL-SAMAD K, Ma S, Austin DE, Chong A, et al
    Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization.
    Am Heart J. 2024 Jul 31:S0002-8703(24)00183-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
59. BURGOS LM, Vila RCB, Ballari FN, Goyeneche A, et al
    Inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure: a randomized pilot study (CAVAL US-AHF study).
    Am Heart J. 2024 Jul 31:S0002-8703(24)00181-9. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
60. SINGH K, Nikhare K, Gandral M, Aithal K, et al
    Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The C-QIP Trial.
    Am Heart J. 2024 Jul 19:S0002-8703(24)00174-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
61. ELLFORS E, Dismorr M, Ruck A, Settergren M, et al
    Predicted prosthesis-patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.
    Am Heart J. 2024 Jul 18:S0002-8703(24)00175-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
62. PINNA GD, Maestri R, Robbi E, Guazzotti G, et al
    Nocturnal Hypoxemic Burden in Patients with Heart Failure: Emerging Prognostic Role of Its Non-Specific Component.
    Am Heart J. 2024 Jul 5:S0002-8703(24)00166-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    June 2024
63. IBEH C, Kulick ER, Boehme AK, Friedman AM, et al
    Incident Stroke in Individuals with Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jun 20:S0002-8703(24)00160-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
64. PICHAN CM, Santivasi WL, Mentz RJ
    A Bridge to Comfort: Palliative Inotrope Infusion for Patients with Heart Failure in Hospice Care.
    Am Heart J. 2024 Jun 15:S0002-8703(24)00159-5. doi: 10.1016/j.ahj.2024.
    PubMed    
    
    
    May 2024
65. KUSNER J, Patel RB, Hu M, Bertoni AG, et al
    Association of Disproportionate Liver Fat with Markers of Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Am Heart J. 2024 May 20:S0002-8703(24)00125-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
66. KITTIPIBUL V, Yaranov DM, Biegus J, Gray JM, et al
    Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure.
    Am Heart J. 2024;271:178-181.
    PubMed     Abstract available
    
    
    April 2024
67. ELKHOLEY K, Asad ZUA, Shehata E, Mustafina I, et al
    Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum.
    Am Heart J. 2024 Apr 27:S0002-8703(24)00104-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
68. GAGNON LR, Hazra D, Perera K, Wang K, et al
    Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort.
    Am Heart J. 2024 Apr 24:S0002-8703(24)00094-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
69. HAMO CE, Mukhopadhyay A, Li X, Zheng Y, et al
    Association between Visit Frequency, Continuity of Care, and Pharmacy Fill Adherence in Heart Failure Patients.
    Am Heart J. 2024 Apr 13:S0002-8703(24)00090-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
70. KEEPANASSERIL A, Pande SN, Suriya Y, Baghel J, et al
    "Comparing the Outcomes of Rheumatic Heart Disease in Pregnancy Complicated with and without Atrial Fibrillation: A Propensity Score Matched Analysis".
    Am Heart J. 2024 Apr 11:S0002-8703(24)00089-9. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
71. MANJA V, Sandhu ATS, Asch S, Frayne S, et al
    Healthcare utilization and left ventricular ejection fraction distribution in methamphetamine use associated heart failure hospitalizations.
    Am Heart J. 2024;270:156-160.
    PubMed     Abstract available
    
    
    
72. SMOLDEREN KG, Romain G, Cleman J, Scierka L, et al
    Variability in guideline-directed medical therapy across sites and operators and long-term mortality and amputation outcomes risk in patients undergoing peripheral vascular interventions.
    Am Heart J. 2024;270:75-85.
    PubMed     Abstract available
    
    
    March 2024
73. ZHANG L, Wang W, Huo X, He G, et al
    Predicting the risk of 1-year mortality among patients hospitalized for acute heart failure in China.
    Am Heart J. 2024 Mar 13:S0002-8703(24)00066-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
74. SAMPAIO RODRIGUES T, Garcia Quarto LJ, Nogueira SC, Theuerle JD, et al
    Door-to-diuretic time and mortality in patients with acute heart failure: A systematic review and meta-analysis.
    Am Heart J. 2024;269:205-209.
    PubMed     Abstract available
    
    
    February 2024
75. SZABO B, Benson L, Savarese G, Hage C, et al
    Previous heart failure hospitalization, spironolactone and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT.
    Am Heart J. 2024 Feb 25:S0002-8703(24)00048-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
76. RAO VN, Sharma A, Stebbins A, Buse JB, et al
    Regional variation in cause of death in patients with type 2 diabetes: insights from EXSCEL: Cause of Death in Type 2 Diabetes.
    Am Heart J. 2024 Feb 21:S0002-8703(24)00040-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
77. ANDERSEN CF, Larsen JH, Jensen J, Omar M, et al
    Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program.
    Am Heart J. 2024 Feb 14:S0002-8703(24)00032-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
78. LAMP J, Wu Y, Lamp S, Afriyie P, et al
    Characterizing Advanced Heart Failure Risk and HemodyNAmic Phenotypes using Interpretable Machine Learning.
    Am Heart J. 2024 Feb 7:S0002-8703(24)00021-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    January 2024
79. ZEITLER EP, Dalgaard F, Abraham WT, Cleland JGF, et al
    Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis.
    Am Heart J. 2024;267:81-90.
    PubMed     Abstract available
    
    
    
80. ROLFS N, Huber C, Schwarzkopf E, Mentzer D, et al
    Clinical course and follow-up of pediatric patients with COVID-19 vaccine-associated myocarditis compared to non-vaccine-associated myocarditis within the prospective multicenter registry-"MYKKE".
    Am Heart J. 2024;267:101-115.
    PubMed     Abstract available
    
    
    December 2023
81. SALERNO PR, Chen Z, Wass S, Motairek I, et al
    Sex-specific Heart Failure Burden Across the United States: Global Burden of Disease 1990-2019.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00348-4. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
82. SIREN M, Leivo J, Anttonen E, Jolly SS, et al
    The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of the Randomized TOTAL Trial.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
83. MONTEMBEAU SC, Rao BR, Mitchell AR, Speight CD, et al
    Integrating Cost into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction (POCKET-COST-HF): A Trial Providing Out-of-pocket Costs for Heart Failure Medications during Clinical Encounters.
    Am Heart J. 2023 Dec 12:S0002-8703(23)00322-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
84. GUNN AH, Warraich HJ, Mentz RJ
    Costs of Care and Financial Hardship Among Patients with Heart Failure.
    Am Heart J. 2023 Dec 6:S0002-8703(23)00330-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    November 2023
85. SAVARESE G, Gatti P, Benson L, Adamo M, et al
    LEFT VENTRICULAR EJECTION FRACTION DIGIT BIAS AND RECLASSIFICATION OF HEART FAILURE WITH MILDLY REDUCED VS. REDUCED EJECTION FRACTION BASED ON THE 2021 DEFINITION AND CLASSIFICATION OF HEART FAILURE: Abbreviated title: DIGIT BIAS AND HEART FAILURE REC
    Am Heart J. 2023 Nov 14:S0002-8703(23)00317-4. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
86. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
87. SALAHUDDIN T, Hebbe A, Daus M, Essien UR, et al
    Trends and Site-level Variation of Novel Cardiovascular Medication Utilization among Patients Admitted for Heart Failure or Coronary Artery Disease in the US Veterans Affairs System: 2017-2021.
    Am Heart J. 2023 Nov 11:S0002-8703(23)00318-6. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    October 2023
88. EGBE AC, Miranda WR, Jain CC, Stephens EH, et al
    Temporal Changes in Clinical Characteristics and Outcomes of Adults With Congenital Heart Disease.
    Am Heart J. 2023;264:1-9.
    PubMed     Abstract available
    
    
    September 2023
89. FLETT A, Cebula A, Nicholas Z, Adam R, et al
    Rationale and study protocol for the BRITISH randomised trial (Using cardiovascular magnetic resonance identified scar as the Benchmark Risk Indication Tool for Implantable cardioverter defibrillators in patients with Non-Ischaemic Cardiomyopathy and
    Am Heart J. 2023 Sep 28:S0002-8703(23)00281-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    August 2023
90. JAMES S, Erlinge D, Storey RF, McGuire DK, et al
    Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
    Am Heart J. 2023 Aug 25:S0002-8703(23)00207-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
91. HARRINGTON J, Mentz RJ, Rockhold FW, Garg J, et al
    Baseline Characteristics of Patients in the Randomized Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency: HEART-FID Trial.
    Am Heart J. 2023 Aug 18:S0002-8703(23)00202-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
92. COX ZL, Siddiqi HK, Stevenson LW, Bales B, et al
    Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design.
    Am Heart J. 2023 Aug 4:S0002-8703(23)00187-4. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    July 2023
93. VINEREANU D, Wojdyla DM, Alexander JH, Lopes RD, et al
    Heart Rate and Death and Hospitalization for Heart Failure in Patients with Persistent or Permanent Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Am Heart J. 2023 Jul 26:S0002-8703(23)00179-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
94. MATASIC DS, Blumenthal RS, Fonarow GC, Gulati M, et al
    Taking the next step in cardiovascular risk reduction: Integrating heart failure and peripheral arterial disease prevention.
    Am Heart J. 2023 Jul 20:S0002-8703(23)00176-X. doi: 10.1016/j.ahj.2023.
    PubMed    
    
    
    
95. BANKE A, Andersson C, D'Souza M, Fosbol E, et al
    Importance of familial predisposition to heart failure to the risk of anthracycline related cardiotoxicity: A nationwide study.
    Am Heart J. 2023 Jul 13:S0002-8703(23)00175-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
96. JEFFERIES JL, Kovesdy CP, Ronco C
    Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action.
    Am Heart J. 2023;261:75-84.
    PubMed     Abstract available
    
    
    
97. PETERS AE, Solomon N, Chiswell K, Fonarow GC, et al
    Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure and Performance of an Adapted Wild-Type ATTR-CM Machine Learning Model: Findings from GWTG-HF.
    Am Heart J. 2023 Jul 1:S0002-8703(23)00169-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    June 2023
98. GANGAVELLI A, Liu Z, Wang J, Okoh A, et al
    Racial Differences in Low Natriuretic Peptide Levels: Implications for Heart Failure Clinical Trials.
    Am Heart J. 2023 Jun 19:S0002-8703(23)00163-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
99. VIOLI F, Castellani V, Menichelli D, Pignatelli P, et al
    GUT BARRIER DYSFUNCTION AND ENDOTOXEMIA IN HEART FAILURE: A DANGEROUS CONNUBIUM?
    Am Heart J. 2023 Jun 8:S0002-8703(23)00146-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
100. MEWTON N, Donal E, Picard F, Derimay F, et al
     Prognostic impact of precipitated cardiac decompensation in symptomatic heart failure with reduced ejection fraction and severe secondary mitral regurgitation.
     Am Heart J. 2023 Jun 2:S0002-8703(23)00137-0. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     May 2023
101. KRONBORG MB, Frausing MHJP, Svendsen JH, Johansen JB, et al
     Does Targeted Positioning of the Left Ventricular Pacing Lead Towards the Latest Local Electrical Activation in Cardiac Resynchronization Therapy Reduce the Incidence of Death or Hospitalization for Heart Failure?
     Am Heart J. 2023 May 21:S0002-8703(23)00129-1. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     
102. ARNOLD SV, Gosch K, Kosiborod M, Wong ND, et al
     Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.
     Am Heart J. 2023 May 8:S0002-8703(23)00112-6. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     
103. CHOUAIRI F, Pinsker B, Miller PE, Fudim M, et al
     Effects of COVID-19 on Heart Failure Admissions.
     Am Heart J. 2023 May 6:S0002-8703(23)00111-4. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     
104. SELAMET TIERNEY ES, Palaniappan L, Leonard M, Long J, et al
     Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
     Am Heart J. 2023;259:68-78.
     PubMed     Abstract available
     
     
     April 2023
105. RAO VN, Cyr D, Wruck L, Sanders G, et al
     Electronic Health Record Characterization and Outcomes of Heart Failure with Preserved Ejection Fraction.
     Am Heart J. 2023 Apr 26:S0002-8703(23)00100-X. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     
106. FU G, Zhou Z, Jian B, Huang S, et al
     Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
     Am Heart J. 2023;258:177-185.
     PubMed     Abstract available
     
     
     
107. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
     Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
     Am Heart J. 2023;258:49-59.
     PubMed     Abstract available
     
     
     
108. MUKHOPADHYAY A, Reynolds HR, Xia Y, Phillips LM, et al
     Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists.
     Am Heart J. 2023;258:38-48.
     PubMed     Abstract available
     
     
     February 2023
109. UPSHAW JN, Parker S, Gregory D, Koethe B, et al
     The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized Controlled Trial.
     Am Heart J. 2023 Feb 24:S0002-8703(23)00042-X. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     
110. YAKU H, Kato T, Morimoto T, Kaneda K, et al
     Rationale and Study design of the GOREISAN for Heart Failure (GOREISAN-HF) trial: A randomized clinical trial.
     Am Heart J. 2023 Feb 23:S0002-8703(23)00045-5. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     January 2023
111. SILVAIN J, Cayla G, Ferrari E, Range G, et al
     betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
     Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
     PubMed     Abstract available
     
     
     October 2021
112. COTTER G, Davison BA, Edwards C, Senger S, et al
     Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials.
     Am Heart J. 2021;240:73-80.
     PubMed     Abstract available
     
     
     June 2021
113. SZUMMER K, Perino AC, Fan J, Kothari M, et al
     Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices.
     Am Heart J. 2021 Jun 9. pii: S0002-8703(21)00149.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.